Cytek Biosciences (CTKB) has introduced an Enhanced Small Particle, or ESP, Detection Option for its Cytek Aurora CS system. This is the first ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Analysts are estimating that Cytek Biosciences will report an earnings per share (EPS) of $0.00. The announcement from Cytek Biosciences is eagerly anticipated, with investors seeking news of ...

Cytek Biosciences (CTKB – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

Cytek’s FSP platform includes its core instruments, the Cytek Aurora™ and Northern Lights™ systems; its cell sorter, the Cytek Aurora CS; the Cytek Orion™ reagent cocktail preparation ...

Cytek Biosciences, Inc. (NASDAQ: CTKB) came out with a quarterly loss of $0.01 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to break-even earnings per share a ...

This content may contain affiliate links. If you would like to support us and use these links to buy something, we may earn a ...

Interested parties may access a live and archived webcast of these presentations on the “Investors” section of the company website at: investors.cytekbio.com. Cytek’s products are for ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Within these photos, the sighted Aurora and the Northern ... $2.2 million shares of Cytek stock for approximately $12.1 million at a weighted average price of $5.41 per share.

Cytek’s FSP platform includes its core instruments, the Cytek Aurora™ and Northern Lights™ systems; its cell sorter, the Cytek Aurora CS; the Cytek Orion™ reagent cocktail preparation ...